Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-10 · accession 0001415889-24-013356 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-16 | 2024-05-10 | MIRM | BJERKHOLT ERIC | CFO | A - Grant | $21.05 | +470 | 14.5K | +3% | +$9,894 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-10 | A | A | 470 | $21.05 | 14,470 | D | — | — |